SPECIAL NOTICE
65 -- 711th
- Notice Date
- 7/19/2017
- Notice Type
- Special Notice
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- General Services Administration, Federal Acquisition Service (FAS), GSA/FAS R5 Contracting Division (5QZA), 230 S. Dearborn Street, Room 3280, Chicago, Illinois, 60604, United States
- ZIP Code
- 60604
- Solicitation Number
- ID05170034
- Archive Date
- 8/3/2017
- Point of Contact
- Holley J. Robinson-Blouse, Phone: 9374274643
- E-Mail Address
-
holley.robinson-blouse@gsa.gov
(holley.robinson-blouse@gsa.gov)
- Small Business Set-Aside
- N/A
- Description
- 1. AGENCY AND CONTRACTING ACTIVITY Agency: 711 th Human Performance Wing U.S. Air Force School of Aerospace Medicine (USAFSAM) Contract Activity: General Services Administration (GSA)/Region 5 Federal Acquisition Services (FAS) Contracting Division 2. NATURE AND/OR DESCRIPTION OF ACTION BEING PROCESSED. The 711 th Human Performance Wing/USAFSAM has a one-time purchase requirement for the Luminex Products. 3. DESCRIPTION OF THE SUPPLIES/SERVICES REQURIED TO MEET THE AGENCY’S NEEDS. USAFSAM/PHE requires reagents/consumable/kits necessary to perform innovative biological testing technologies. These reagents are required for laboratory diagnostic testing support for 213 DoD MTFs and 9 million patients/beneficiaries. The laboratory testing is utilized for the diagnosis and patient care for respiratory viruses and bacteria. The estimated price is $. 4. STATUTORY AUTHORITY PERMITTING OTHER THAN FULL AND OPEN COMPETITION Citation: 10 U.S.C. 2304(c)(1), only one responsible source and no other supplies will satisfy the agency requirements. 5. DEMONSTRATION THAT THE CONTRACTOR’S UNIQUE QUALIFICATIONS OR NATURE OF THE ACQUISITION REQUIRES THE USE OF ONLY ONE RESPONSIBLE SOURCE AUTHORITY. Reagents must be FDA approved to function on the Luminex Magpix instrument, owned by USAFSAM/PHE, and the vendor will comply with all FDA regulations. Luminex is the sole manufacturer of the products. 6. DESCRIPTION OF EFFORTS MADE TO ENSURE THAT OFFERS ARE SOLICITED FROM AS MANY POTENTIAL SOURCES AS DEEMED PRACTICABLE. Luminex is the sole manufacturer of the commercial product with no resalers. 7. DETERMINATION BY THE PROGRAM MANAGER/CONTRACTING OFFICER THAT THE ANTICIPATED COST TO THE GOVERNMENT WILL BE FAIR AND REASONABLE. The GSA Contracting Officer will determine the price as fair and reasonable. The GSA Contracting Officer will use the distributor’s public price list to determine the price as reasonable. 8. DESCRIPTION OF THE MARKET RESEARCH CONDUCTED AND THE RESULTS, OR A STATEMENT OF THE REASONS MARKET RESEARCH WAS NOT CONDUCTED. Market research determined that there is only one distributor of the products. The North American Industry Classification System (NAICS) for the products is 325413, In-Vitro Diagnostic Substance Manufacturing. The size standard is 1250 employees. In-Vitro Diagnostic is a small business under NAICS 325413. 9. ANY OTHER FACTS SUPPORTING THE USE OF OTHER THAN FULL AND OPEN COMPET ITION. None 10. A LISTING OF SOURCES, IF ANY, THAT EXPRESSED, IN WRITING, AN INTEREST IN THE ACQUISITION. None 11. A STATEMENT OF THE ACTIONS, IF ANY, THE AGENCY MAY TAKE TO REMOVE OR OVERCOME ANY BARRIERS TO COMPETITION BEFORE MAKING ANY SUBSEQUENT ACQUISITION FOR THE SUPPLIES OR SERVICES REQURIED. Any future purchase for the exact item will need to be with Luminex to meet the needs of the 711th. 12. PROGRAM MANAGER CERTIFICATION. I certify that the data supporting the recommended use of other than full and open competition is accurate and complete to the best of my knowledge.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/notices/a2907d62e7539293276f0334722e9dfb)
- Place of Performance
- Address: WPAFB, United States
- Record
- SN04586613-W 20170721/170719235548-a2907d62e7539293276f0334722e9dfb (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |